Interacting with heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNPA2B1) and so inhibiting NF-kB signaling has been demonstrated to prevent HCC metastasis. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.